146 related articles for article (PubMed ID: 34693506)
1. Long non-coding RNA panel as a molecular biomarker in glioma.
Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
[TBL] [Abstract][Full Text] [Related]
2. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
[TBL] [Abstract][Full Text] [Related]
3. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
[TBL] [Abstract][Full Text] [Related]
4. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma.
Yue H; Zhu J; Xie S; Li F; Xu Q
Biomed Pharmacother; 2016 Jul; 81():203-209. PubMed ID: 27261595
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
Xu C; He T; Li Z; Liu H; Ding B
Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the expression of long non-coding RNA PVT1 in glioma.
Fang J; Huang J
Cancer Biomark; 2019; 24(4):509-513. PubMed ID: 30909189
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA AFAP1-AS1 accelerates invasion and predicts poor prognosis of glioma.
Wang Y; Lan Q
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5223-5229. PubMed ID: 30178845
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
11. LncRNA as potential biomarker and therapeutic target in glioma.
Xu X; Liang Y; Gareev I; Liang Y; Liu R; Wang N; Yang G
Mol Biol Rep; 2023 Jan; 50(1):841-851. PubMed ID: 36331751
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
Yang JX; Liu B; Yang BY; Meng Q
Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
[TBL] [Abstract][Full Text] [Related]
15. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs in glioma progression.
Xi J; Sun Q; Ma L; Kang J
Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
Wei N; Wei H; Zhang H
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
Xin J; Zhao YH; Zhang XY; Tian LQ
Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ARRDC1-AS1 is activated by STAT1 and exerts oncogenic properties by sponging miR-432-5p/PRMT5 axis in glioma.
Zou XD; Zang Q; Zhang ZZ; Lu YQ; Jin X; Wu Y
Biochem Biophys Res Commun; 2021 Jan; 534():511-518. PubMed ID: 33220929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
